DWA
VCYT icon

Dorsey Wright & Associates’s Veracyte VCYT Stock Holding History

Dorsey Wright & Associates’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-693
Closed -$34K – 378
2020
Q4 		$34K Buy
693
+173
+33% +$8.02K 0.01% 161
2020
Q3 		$17K Sell
520
-173
-25% -$5.5K ﹤0.01% 161
2020
Q2 		$19K Hold
693
– – ﹤0.01% 168
2020
Q1 		$17K Sell
693
-79
-10% -$1.99K 0.01% 112
2019
Q4 		$22K Hold
772
– – 0.01% 124
2019
Q3 		$19K Buy
772
+2
+0.3% +$53 ﹤0.01% 140
2019
Q2 		$22K Buy
770
+192
+33% +$4.8K 0.01% 145
2019
Q1 		$14K Sell
578
-576
-50% -$11K ﹤0.01% 153
2018
Q4 		$15K Buy
+1,154
New +$13.6K ﹤0.01% 201

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Dorsey Wright & Associates's VCYT Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of Veracyte (VCYT) in Q1 2021, closing a stake of 693 shares — an estimated $34K sold.

Dorsey Wright & Associates first reported a position in VCYT in Q4 2018 and held it in 9 quarters. The position peaked at $34K in Q4 2020. 235 funds tracked by Wall St. Rank hold VCYT as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining Veracyte position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 693 Veracyte shares in Q1 2021, an estimated $34K.
  • Dorsey Wright & Associates first reported a position in Veracyte in Q4 2018 and held it in 9 quarters.
  • Dorsey Wright & Associates's Veracyte position peaked at $34K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Veracyte as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.